卵母细胞体外成熟用于自身免疫性早发性卵巢功能不全患者的生育力保存
一例36岁闭经女性诊断为自身免疫性早发性卵巢功能不全,在卵巢刺激失败后采用卵母细胞体外成熟(IVM)两个周期,获8枚 cleavage 期胚胎冷冻;1年后复苏移植2枚胚胎,足月分娩两男婴。作者报告首例通过IVM在自身免疫性POI患者中实现妊娠和活产。
要点
- 自身免疫性POI患者仍可能有正常数量的窦卵泡,可考虑IVM用于生育力保存。
- 卵巢刺激失败后,从剩余窦卵泡穿刺未成熟卵母细胞行IVM可获得成熟卵母细胞。
- 该例为首次在自身免疫性POI中通过IVM实现妊娠和活产的报告。
核心结论
- 作者报告首例通过IVM为自身免疫性POI患者进行生育力保存并实现妊娠和活产。
- 作者认为该结果的确认将改变对年轻自身免疫性POI患者的管理,这类患者通常不被视为生育力保存的候选者。
研究设计与样本
- 病例报告,设置于大学医院。
- 患者为36岁闭经女性,诊断为自身免疫性POI,转诊进行生育力保存咨询。
主要发现
- 间隔4周两次血清FSH为21.0和36.3 mIU/mL,LH为35.0和60.0 mIU/mL,接近绝经范围。
- 血清抗苗勒管激素低(0.76和0.65 ng/mL),但窦卵泡总数意外保持正常(24和22)。
- 血清抗过氧化物酶抗体、抗21-羟化酶抗体和抗卵巢抗体显著,诊断为自身免疫性多内分泌病。
- 重组FSH 300 IU/天共10天刺激后卵泡生长失败,遂行IVM两个周期:人绒毛膜促性腺激素 priming 后分别获6和10个卵丘-卵母细胞复合体,4和8个MII卵母细胞。
- 经卵胞浆内单精子注射后,共8枚 cleavage 期胚胎冷冻;1年后复苏移植2枚胚胎,患者妊娠并足月分娩两男婴。
关键数值与推荐
- IVM前卵巢刺激方案为重组FSH 300 IU/天共10天,卵泡生长失败。
- 子宫内膜准备:17β-雌二醇2 mg/天阴道给药14天,随后联合孕酮600 mg/天阴道给药。
临床怎么用
- 作者认为该结果的确认将改变对年轻自身免疫性POI患者的管理,这类患者通常不被视为生育力保存的候选者,寻求妊娠时常被转诊至卵子捐赠。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To test whether in vitro maturation (IVM) of oocytes is an option for preserving the fertility of women diagnosed with premature ovarian insufficiency (POI). DESIGN: Case report. SETTING: University hospital. PATIENT(S): A 36-year-old amenorrheic patient was referred for fertility preservation (FP) counseling with a diagnosis of autoimmune POI. Serum follicle-stimulating hormone (21.0 and 36.3 mIU/mL) and luteinizing hormone (35.0 and 60.0 mIU/mL) levels taken 4 weeks apart were around the menopausal range. Although serum antimüllerian hormone level was low (0.76 and 0.65 ng/mL), total counts of antral follicles remained unexpectedly normal (24 and 22). Significant levels of serum antiperoxidase, anti-21-hydroxylase, and antiovary antibodies led to the diagnosis of autoimmune polyendocrinopathy. Due to the unknown time before follicular exhaustion, we undertook a FP program. INTERVENTION(S): After unsuccessful follicular growth following a trial of ovarian stimulation using recombinant follicle-stimulating hormone (300 IU/day for 10 days), we decided to try IVM of immature oocytes aspirated from the remaining antral-stage follicles. MAIN OUTCOME MEASURE(S): Obtention of immature oocyte capable of maturing in vitro in a context of acute ovarian dysfunction. RESULT(S): Two cycles of IVM were performed, leading, after human chorionic gonadotropin priming, to six and 10 cumulus-oocyte complexes recovered and four and eight metaphase II oocytes. Finally, after intracytoplasmic sperm injection, a total of eight cleavage-stage embryos were frozen. When the patient presented in the clinic 1 year later for reutilization of the cryopreserved embryos, thyroid and adrenal functions were controlled with levothyroxine and hydrocortisone. Endometrium was primed with 17ß-estradiol (2 mg/day, vaginally) for 14 days. Progesterone (600 mg/day, vaginally) was subsequently combined with E2. Two embryos were thawed and further transferred into the uterus. The patient became pregnant and uneventfully delivered two baby boys at term. CONCLUSION(S): We report the first pregnancy and live birth achieved using IVM for FP in a woman diagnosed with autoimmune POI. The confirmation of our results would lead to modification in the management of young women diagnosed with autoimmune POI, who are usually not considered candidates for FP and often referred for egg donation when seeking pregnancy.
引用
- Grynberg M, Jacquesson L, Sifer C, et al. In vitro maturation of oocytes for preserving fertility in autoimmune premature ovarian insufficiency. Fertil Steril. 2020. PMID: 32709383. doi:10.1016/j.fertnstert.2020.04.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。